loading

Neuphoria Therapeutics Inc Azioni (NEUP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
452.97%
6.7001
1.2116 4.0608 5.6527 5.8218
Depreciation and Amortization
0.1657
- 0.1658 0.1658 0.1656
Operating Income/Loss
356.07%
-5.5259
-1.2116 -4.0608 -5.6527 -5.835
Nonoperating Income/Loss
12.67%
0.5867
0.6718 5.8901 -4.2886 -3.3152
Income/Loss From Continuing Operations Before Tax
814.92%
-4.9392
-0.5399 1.8293 -9.9413 -9.1503
Income Tax Expense/Benefit
0.00%
-0.0348
-0.0348 -0.0348 -0.0348 -0.2666
Net Income/Loss
871.06%
-4.9045
-0.5051 1.8641 -9.9065 -8.8837
FTH FTH
$24.32
price down icon 6.55%
$7.49
price down icon 4.22%
$3.625
price down icon 9.15%
WVE WVE
$3.34
price down icon 3.47%
$20.23
price down icon 4.21%
$11.23
price down icon 1.40%
Capitalizzazione:     |  Volume (24 ore):